Can you hear me now?: The Tipline for 21 August 2018
Verizon is calling for the Supreme Court to elaborate on the scope of its American Express ruling, which it issued less than two months ago. Meanwhile, Mylan and Pfizer have successfully dismissed some of the antitrust claims brought against them, but consumers’ main accusation of EpiPen monopolisation remains intact. We also have news on eight more restaurant chains removing “no poach” language from their franchise contracts, and the New York Times endorsing an antitrust scholar to be the next attorney general of New York.
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is the complete source of news and analysis for competition practitioners. It keeps you up to speed with the issues and trends that matter, giving you the detail, and depth, you need to operate successfully.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10